DNLI
Price
$21.78
Change
+$5.61 (+34.69%)
Updated
Feb 3 closing price
Capitalization
3.4B
26 days until earnings call
Intraday BUY SELL Signals
ZNTL
Price
$2.82
Change
+$1.01 (+55.80%)
Updated
Feb 3 closing price
Capitalization
182.6M
28 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DNLI vs ZNTL

Header iconDNLI vs ZNTL Comparison
Open Charts DNLI vs ZNTLBanner chart's image
Denali Therapeutics
Price$21.78
Change+$5.61 (+34.69%)
Volume$1.73M
Capitalization3.4B
Zentalis Pharmaceuticals
Price$2.82
Change+$1.01 (+55.80%)
Volume$1.13M
Capitalization182.6M
DNLI vs ZNTL Comparison Chart in %
DNLI
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DNLI vs. ZNTL commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and ZNTL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (DNLI: $21.78 vs. ZNTL: $2.82)
Brand notoriety: DNLI and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 101% vs. ZNTL: 70%
Market capitalization -- DNLI: $3.4B vs. ZNTL: $182.6M
DNLI [@Biotechnology] is valued at $3.4B. ZNTL’s [@Biotechnology] market capitalization is $182.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, ZNTL is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 6 TA indicator(s) are bullish while ZNTL’s TA Score has 5 bullish TA indicator(s).

  • DNLI’s TA Score: 6 bullish, 4 bearish.
  • ZNTL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than ZNTL.

Price Growth

DNLI (@Biotechnology) experienced а +2.49% price change this week, while ZNTL (@Biotechnology) price change was -3.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

Reported Earning Dates

DNLI is expected to report earnings on Mar 02, 2026.

ZNTL is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.4B) has a higher market cap than ZNTL($183M). ZNTL YTD gains are higher at: 108.889 vs. DNLI (31.920). ZNTL has higher annual earnings (EBITDA): -152.83M vs. DNLI (-534.17M). DNLI has more cash in the bank: 848M vs. ZNTL (281M). ZNTL has less debt than DNLI: ZNTL (36.7M) vs DNLI (44.4M). ZNTL has higher revenues than DNLI: ZNTL (26.9M) vs DNLI (0).
DNLIZNTLDNLI / ZNTL
Capitalization3.4B183M1,860%
EBITDA-534.17M-152.83M350%
Gain YTD31.920108.88929%
P/E RatioN/AN/A-
Revenue026.9M-
Total Cash848M281M302%
Total Debt44.4M36.7M121%
FUNDAMENTALS RATINGS
DNLI vs ZNTL: Fundamental Ratings
DNLI
ZNTL
OUTLOOK RATING
1..100
1783
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
13
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
3835
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZNTL's Valuation (13) in the null industry is significantly better than the same rating for DNLI (93) in the Biotechnology industry. This means that ZNTL’s stock grew significantly faster than DNLI’s over the last 12 months.

ZNTL's Profit vs Risk Rating (100) in the null industry is in the same range as DNLI (100) in the Biotechnology industry. This means that ZNTL’s stock grew similarly to DNLI’s over the last 12 months.

ZNTL's SMR Rating (97) in the null industry is in the same range as DNLI (97) in the Biotechnology industry. This means that ZNTL’s stock grew similarly to DNLI’s over the last 12 months.

ZNTL's Price Growth Rating (35) in the null industry is in the same range as DNLI (38) in the Biotechnology industry. This means that ZNTL’s stock grew similarly to DNLI’s over the last 12 months.

DNLI's P/E Growth Rating (99) in the Biotechnology industry is in the same range as ZNTL (100) in the null industry. This means that DNLI’s stock grew similarly to ZNTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNLIZNTL
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 16 days ago
83%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGJTF69.811.85
+2.72%
Cargojet, Inc.
FSNUY14.440.28
+1.98%
Fresenius SE & Co. KGaA
KOBNF24.10N/A
N/A
Kobe Bussan Co., Ltd.
ZPHRF0.04N/A
-2.38%
ZEPHYR ENERGY PLC.
CLCFF0.03N/A
-8.34%
Christina Lake Cannabis Corp.

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with VIR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-4.22%
VIR - DNLI
55%
Loosely correlated
-0.39%
RGNX - DNLI
54%
Loosely correlated
+0.74%
BEAM - DNLI
54%
Loosely correlated
-0.11%
OCUL - DNLI
54%
Loosely correlated
-6.99%
VRDN - DNLI
52%
Loosely correlated
-3.92%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with NGNE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+12.35%
NGNE - ZNTL
49%
Loosely correlated
-4.20%
RVMD - ZNTL
48%
Loosely correlated
-1.22%
DNLI - ZNTL
43%
Loosely correlated
-4.22%
NKTX - ZNTL
43%
Loosely correlated
+2.78%
FATE - ZNTL
42%
Loosely correlated
-5.69%
More